A234080 Stock Overview
JW Lifescience Corporation ofrece soluciones nacionales de infusión en Corea del Sur y a escala internacional.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
JW Lifescience Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩12,420.00 |
| 52 Week High | ₩15,160.00 |
| 52 Week Low | ₩11,100.00 |
| Beta | 0.56 |
| 1 Month Change | -1.43% |
| 3 Month Change | -2.74% |
| 1 Year Change | 6.15% |
| 3 Year Change | -35.31% |
| 5 Year Change | -48.78% |
| Change since IPO | -42.17% |
Recent News & Updates
Recent updates
We Think JW Lifescience (KRX:234080) Can Manage Its Debt With Ease
Apr 20
Introducing JW Lifescience (KRX:234080), A Stock That Climbed 36% In The Last Year
Mar 11What Type Of Shareholders Make Up JW Lifescience Corporation's (KRX:234080) Share Registry?
Feb 21Is JW Lifescience Corporation (KRX:234080) A Smart Pick For Income Investors?
Feb 02
We Think JW Lifescience (KRX:234080) Can Manage Its Debt With Ease
Jan 12Is It Smart To Buy JW Lifescience Corporation (KRX:234080) Before It Goes Ex-Dividend?
Dec 23Is JW Lifescience Corporation's (KRX:234080) Recent Performance Tethered To Its Attractive Financial Prospects?
Dec 23How Much Did JW Lifescience's(KRX:234080) Shareholders Earn From Share Price Movements Over The Last Three Years?
Nov 27Shareholder Returns
| A234080 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | -0.08% | -5.8% | -1.5% |
| 1Y | 6.2% | 10.1% | 7.5% |
Rentabilidad frente al sector: A234080 obtuvo unos resultados inferiores a los del sector KR Pharmaceuticals , que el año pasado arrojó un rendimiento del 15.6%.
Rentabilidad vs. Mercado: A234080 obtuvo unos resultados inferiores a los del mercado KR, que fue del 11.3% el año pasado.
Price Volatility
| A234080 volatility | |
|---|---|
| A234080 Average Weekly Movement | 2.0% |
| Pharmaceuticals Industry Average Movement | 4.7% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in KR Market | 12.0% |
| 10% least volatile stocks in KR Market | 2.4% |
Precio estable de las acciones: A234080 no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de A234080 (2%) se ha mantenido estable durante el año pasado.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 256 | Sungnam Cha | https://www.jw-lifescience.co.kr |
JW Lifescience Corporation suministra soluciones de infusión nacionales en Corea del Sur e internacionales. La empresa ofrece fluidos intravenosos básicos que incluyen agua, electrolitos y glucosa; soluciones de infusión de nutrientes, como aminoácidos, lípidos, proteínas, vitaminas y minerales; y soluciones de infusión especiales. La empresa era conocida anteriormente como JW Co. Ltd.
JW Lifescience Corporation Fundamentals Summary
| A234080 fundamental statistics | |
|---|---|
| Market cap | ₩192.32b |
| Earnings (TTM) | ₩28.14b |
| Revenue (TTM) | ₩206.86b |
6.8x
P/E Ratio0.9x
P/S RatioIs A234080 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A234080 income statement (TTM) | |
|---|---|
| Revenue | ₩206.86b |
| Cost of Revenue | ₩154.51b |
| Gross Profit | ₩52.35b |
| Other Expenses | ₩24.21b |
| Earnings | ₩28.14b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.82k |
| Gross Margin | 25.31% |
| Net Profit Margin | 13.61% |
| Debt/Equity Ratio | 29.0% |
How did A234080 perform over the long term?
See historical performance and comparison